Activation of STAT5 triggers proliferation and contributes to anti-apoptotic signalling mediated by the oncogenic Xmrk kinase (Q40744434)

23 September 2017

title

Activation of STAT5 triggers proliferation and contributes to anti-apoptotic signalling mediated by the oncogenic Xmrk kinase (English)

1 reference

23 September 2017

1 reference

4

Manfred Schartl

1 reference

23 September 2017

Jessica C Morcinek

1

1 reference

23 September 2017

Christin Weisser

series ordinal

2

1 reference

23 September 2017

Eva Geissinger

series ordinal

3

1 reference

23 September 2017

Claudia Wellbrock

series ordinal

5

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

23 September 2017

1 reference

23 September 2017

volume

21

1 reference

23 September 2017

issue

11

1 reference

23 September 2017

page(s)

1668-1678

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1205148

23 September 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

EGF receptor deletions define a region specifically mediating STAT transcription factor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Interferon-alpha inhibits proliferation of Ba/F3 cells by interfering with interleukin-3 action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Autocrine and paracrine regulation by cytokines and growth factors in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

In bone marrow derived Baf-3 cells, inhibition of apoptosis by IL-3 is mediated by two independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

A chemiluminescence-based method for the detection and quantification of antigen-antibody interactions on the surface of eukaryotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Selective coupling of STAT factors to the mouse prolactin receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Trans receptor inhibition of human glioblastoma cells by erbB family ectodomains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Interleukin-3, Erythropoietin, and Prolactin Activate a STAT5-like Factor in Lymphoid Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

The cellular response to neuregulins is governed by complex interactions of the erbB receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Regulation of the Jak2 tyrosine kinase by its pseudokinase domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Signalling by the oncogenic receptor tyrosine kinase Xmrk leads to activation of STAT5 in Xiphophorus melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Multiple binding sites in the growth factor receptor Xmrk mediate binding to p59fyn, GRB2 and Shc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Novel putative receptor tyrosine kinase encoded by the melanoma-inducing Tu locus in Xiphophorus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Proto-oncogene expression in dermal naevi and melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Raf/MAPK and rapamycin-sensitive pathways mediate the anti-apoptotic function of p21Ras in IL-3-dependent hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

Specific activation of a STAT family member in Xiphophorus melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

7 January 2021

Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

7 January 2021

Active signaling by Neu in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

7 January 2021

Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken/human receptor molecules.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

7 January 2021

Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

7 January 2021

Activation of phosphatidylinositol 3-kinase by a complex of p59fyn and the receptor tyrosine kinase Xmrk is involved in malignant transformation of pigment cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

7 January 2021

The Xmrk receptor tyrosine kinase is activated in Xiphophorus malignant melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205148

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1205148

1 reference

Dimensions Publication ID

23 September 2017

1046238242

0 references

1 reference